Table 2. Hazard ratio for death of patients in baseline of JBR.10.
Univariate analysis | Multivariate analysis | |||||
---|---|---|---|---|---|---|
HR | 95 % CI | p-value | HR | 95% CI | p-value | |
Age | ||||||
<65/≥65 | 1.839 | 1.101-3.071 | 0.0198 | 1.89 | 1.131-3.157 | 0.0151 |
Sex | ||||||
Female/male | 0.617 | 0.339-1.236 | 0.1145 | |||
Stage of disease | ||||||
IB/II | 1.734 | 1.042-2.884 | 0.0341 | 1.782 | 1.070-2.967 | 0.0263 |
Pahological subtype | ||||||
Non-SCC/SCC | 0.620 | 0.359-1.069 | 0.0856 | |||
Expression of ACTN4 | ||||||
Positive/negative | 1.036 | 0.588-1.994 | 0.9143 | |||
Treatment recived | ||||||
Observation alone / adjuvant chemotherapy | 0.796 | 0.479-1.321 | 0.3771 |
The clinical data was according to refernce **. HR; hazard ratio, CI, confidatial interval, SCC: squamouse cell carcinoma.